Penny Stock Under Rs 30 Hit Back-to-Back Five Upper Circuit: Promoter Group Member Offloads Entire 5.10% Stake in Off-Market Deal
DSIJ Intelligence-2 / 17 Nov 2025/ Categories: Mindshare, Penny Stocks, Trending
Over the past 18 months, the company has delivered returns of 67 per cent and 225 per cent, respectively.
Take Solutions is a Chennai-based healthcare-focused company offering technology-led services across Life Sciences and Supply Chain Management sectors. Its operations include clinical research support, generics assistance, regulatory submissions, and pharmacovigilance services.
The company declared its Q2 FY26 results on October 27, 2025. Take Solutions reported no operating revenue for the quarter, similar to Q2 FY25, while Q1 FY26 had recorded a marginal Rs 0.04 crore revenue. Despite muted operational activity, the company posted a consolidated net profit of Rs 6.29 crore in Q2 FY26, compared to a loss of Rs 1.58 crore a year earlier. Sequentially, profits improved from a Rs 0.91 crore loss in Q1 FY26 to a gain in the September quarter.
The quarterly profit was largely driven by gains from discontinued operations of its wholly owned subsidiary, Ecron Acunova Limited (EAL).
Take Solutions saw a major change in its promoter shareholding in November 2025. Esyspro Infotech Limited, a promoter group entity, sold its entire 5.10 per cent stake in an off-market deal executed on November 6, 2025. The transaction involved 75,40,998 shares valued at Rs 52,78,698, excluding Taxes, brokerage, or other charges. Following this sale, Esyspro Infotech’s holding in Take Solutions reduced to zero, marking a full exit.
Founded in 2000, Take Solutions operates globally in Life Sciences and Supply Chain Management, providing services across clinical, regulatory, safety, and supply chain functions. Its Life Sciences operations include clinical trials, BA/BE studies, regulatory filings, and pharmacovigilance, while its supply chain segment offers engineering support, process automation, and product re-engineering. The company serves pharmaceutical, biotech, medical device, and generics clients across India, the US, Europe, and other international markets.
Take Solutions, with a market capitalisation of Rs 423 crore, touched a 5 per cent Upper Circuit on Monday, touching its 52-week high. The stock has maintained back-to-back upper circuits for the last five trading sessions, excluding this one. Over the past 18 months, the company has delivered returns of 67 per cent and 225 per cent, respectively.
Disclaimer: The article is for informational purposes only and not investment advice.